Literature DB >> 8665090

Heterosexual HIV transmission.

K H Mayer1, D J Anderson.   

Abstract

Most of the people now living with HIV acquired the infection through heterosexual intercourse. HIV transmission has been facilitated by (a) concomitant sexually transmitted diseases (STDs), (b) the presence of social conditions that create core groups who have frequent and numerous partners, (c) sexual practices associated with bleeding (i.e., trauma, sex during menses) as well as noncircumcision, (d) cervical ectopy, and (e) anal sex. HIV may be found both cell-free and as intracellular virus in genital tract secretion, and may be sexually transmitted through either mechanism. HIV titers in genital tract secretions vary by several logs between people and within individuals over time, being greatest just after seroconversion and with advanced immunosuppression, concomitant genital tract inflammation (including STDs), and decreasing (but not to zero) with antiretroviral therapy. The per-contact transmission efficiency rate is highly variable, ranging from > 3% to < 1 per thousand contacts, with male-to-female HIV transmission generally being more efficient than vice versa. Control of the heterosexual HIV epidemic will necessitate a multidisciplinary approach, utilizing direct biological approaches (e.g., culturally specific and behavioral interventions, as well as more fundamental community changes that decrease societal norms that augment unsafe practices.

Entities:  

Mesh:

Year:  1995        PMID: 8665090

Source DB:  PubMed          Journal:  Infect Agents Dis        ISSN: 1056-2044


  15 in total

1.  In vitro evaluation of viability, integrity, and inflammation in genital epithelia upon exposure to pharmaceutical excipients and candidate microbicides.

Authors:  Youssef Gali; Olivier Delezay; Joachim Brouwers; Noura Addad; Patrick Augustijns; Thomas Bourlet; Hind Hamzeh-Cognasse; Kevin K Ariën; Bruno Pozzetto; Guido Vanham
Journal:  Antimicrob Agents Chemother       Date:  2010-10-04       Impact factor: 5.191

2.  Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system.

Authors:  Franck Lemiale; Wing-pui Kong; Levent M Akyürek; Xu Ling; Yue Huang; Bimal K Chakrabarti; Michael Eckhaus; Gary J Nabel
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

3.  The microbicidal agent C31G inhibits Chlamydia trachomatis infectivity in vitro.

Authors:  P B Wyrick; S T Knight; D G Gerbig; J E Raulston; C H Davis; T R Paul; D Malamud
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

4.  Binding of LFA-1 (CD11a) to intercellular adhesion molecule 3 (ICAM-3; CD50) and ICAM-2 (CD102) triggers transmigration of human immunodeficiency virus type 1-infected monocytes through mucosal epithelial cells.

Authors:  Marie-Paule Carreno; Nicolas Chomont; Michel D Kazatchkine; Theano Irinopoulou; Corrine Krief; Ali-Si Mohamed; Laurent Andreoletti; Mathieu Matta; Laurent Belec
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

5.  Secretory leukocyte protease inhibitor inhibits infection of monocytes and lymphocytes with human immunodeficiency virus type 1 but does not interfere with transcytosis of cell-associated virus across tight epithelial barriers.

Authors:  H Hocini; P Becquart; H Bouhlal; H Adle-Biassette; M D Kazatchkine; L Bélec
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

6.  Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluids.

Authors:  Shamim H Kazmi; Julian R Naglik; Simon P Sweet; Robert W Evans; Siobhan O'Shea; Jangu E Banatvala; Stephen J Challacombe
Journal:  Clin Vaccine Immunol       Date:  2006-08-23

Review 7.  Immunobiology of genital tract trauma: endocrine regulation of HIV acquisition in women following sexual assault or genital tract mutilation.

Authors:  Mimi Ghosh; Marta Rodriguez-Garcia; Charles R Wira
Journal:  Am J Reprod Immunol       Date:  2012-10-04       Impact factor: 3.886

Review 8.  The potential role of biomarkers in HIV preventive vaccine trials.

Authors:  Ellen Maclachlan; Kenneth H Mayer; Ruanne Barnabas; Jorge Sanchez; Beryl Koblin; Ann Duerr
Journal:  J Acquir Immune Defic Syndr       Date:  2009-08-15       Impact factor: 3.731

9.  Multicenter quality control for the detection of hepatitis C virus RNA in seminal plasma specimens.

Authors:  Thomas Bourlet; Rachel Levy; Silvy Laporte; Stéphane Blachier; Laurence Bocket; Guy Cassuto; Lionel Chollet; Marianne Leruez-Ville; Anne Maertens; Fabienne Mousnier; Christophe Pasquier; Christopher Payan; Bertrand Pellegrin; Evelyne Schvoerer; Patricia Zavadzki; Jacques Chouteau; Gilles Duverlie; Jacques Izopet; Françoise Lunel-Fabiani; Jean-Michel Pawlotsky; Nerina Profizi; Christine Rouzioux; Françoise Stoll-Keller; Vincent Thibault; Pierre Wattré; Bruno Pozzetto
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

Review 10.  HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention.

Authors:  Rebecca F Baggaley; Richard G White; Marie-Claude Boily
Journal:  Int J Epidemiol       Date:  2010-04-20       Impact factor: 7.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.